Literature DB >> 10373610

The Benefit of a Roseobacter Species on the Survival of Scallop Larvae.

.   

Abstract

: A marine strain (BS107), identified as a Roseobacter species, was antagonistic to Vibrio species on agar plates. Results suggested that the inhibitory effect was displayed only in the presence of another bacterium. Quantification of the antibacterial activity showed that 48-hour-coculture supernatants from BS107 and another bacterial strain (V. anguillarum 408) reached the highest titers of bacterial inhibition. The antibacterial substance was also liberated when supernatants from V. anguillarum 408 were added to pure cultures of the inhibition-productive bacterium. The presence of a proteinaceous molecule may induce BS107 to display the inhibitory effect. The antibacterial substance was sensitive to trypsin (8000 U/ml) and stable at 100 degrees C. Cell extracts of the isolate BS107 (10(6) cells/ml) significantly enhanced scallop larval survival, thus being beneficial to the rearing process.

Entities:  

Year:  1999        PMID: 10373610     DOI: 10.1007/pl00011751

Source DB:  PubMed          Journal:  Mar Biotechnol (NY)        ISSN: 1436-2228            Impact factor:   3.619


  32 in total

1.  Antibiotic production by a Roseobacter clade-affiliated species from the German Wadden Sea and its antagonistic effects on indigenous isolates.

Authors:  Thorsten Brinkhoff; Gabriela Bach; Thorsten Heidorn; Lanfang Liang; Andrea Schlingloff; Meinhard Simon
Journal:  Appl Environ Microbiol       Date:  2004-04       Impact factor: 4.792

2.  Ecology, inhibitory activity, and morphogenesis of a marine antagonistic bacterium belonging to the Roseobacter clade.

Authors:  Jesper Bartholin Bruhn; Kristian Fog Nielsen; Mette Hjelm; Michael Hansen; José Bresciani; Stefan Schulz; Lone Gram
Journal:  Appl Environ Microbiol       Date:  2005-11       Impact factor: 4.792

3.  Culture conditions of Roseobacter strain 27-4 affect its attachment and biofilm formation as quantified by real-time PCR.

Authors:  Jesper Bartholin Bruhn; Janus Anders Juul Haagensen; Dorthe Bagge-Ravn; Lone Gram
Journal:  Appl Environ Microbiol       Date:  2006-04       Impact factor: 4.792

4.  Bacteria of the Roseobacter clade show potential for secondary metabolite production.

Authors:  Torben Martens; Lone Gram; Hans-Peter Grossart; Daniel Kessler; Rolf Müller; Meinhard Simon; Silke C Wenzel; Thorsten Brinkhoff
Journal:  Microb Ecol       Date:  2007-03-10       Impact factor: 4.552

Review 5.  A review of the functionality of probiotics in the larviculture food chain.

Authors:  Nguyen Thi Ngoc Tinh; Kristof Dierckens; Patrick Sorgeloos; Peter Bossier
Journal:  Mar Biotechnol (NY)       Date:  2007-11-27       Impact factor: 3.619

6.  Cross-ocean distribution of Rhodobacterales bacteria as primary surface colonizers in temperate coastal marine waters.

Authors:  Hongyue Dang; Tiegang Li; Mingna Chen; Guiqiao Huang
Journal:  Appl Environ Microbiol       Date:  2007-10-26       Impact factor: 4.792

Review 7.  Surface colonization by marine roseobacters: integrating genotype and phenotype.

Authors:  Rachael N Slightom; Alison Buchan
Journal:  Appl Environ Microbiol       Date:  2009-08-07       Impact factor: 4.792

8.  Purification and partial identification of novel antimicrobial protein from marine bacterium Pseudoalteromonas species strain X153.

Authors:  Arlette Longeon; Jean Peduzzi; Michel Barthélemy; Sophie Corre; Jean-Louis Nicolas; Michéle Guyot
Journal:  Mar Biotechnol (NY)       Date:  2004 Nov-Dec       Impact factor: 3.619

9.  Phaeobacter and Ruegeria species of the Roseobacter clade colonize separate niches in a Danish Turbot (Scophthalmus maximus)-rearing farm and antagonize Vibrio anguillarum under different growth conditions.

Authors:  Cisse Hedegaard Porsby; Kristian Fog Nielsen; Lone Gram
Journal:  Appl Environ Microbiol       Date:  2008-10-24       Impact factor: 4.792

Review 10.  The dual role of bacteriocins as anti- and probiotics.

Authors:  O Gillor; A Etzion; M A Riley
Journal:  Appl Microbiol Biotechnol       Date:  2008-10-14       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.